MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+10.21%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$232M
AUM Growth
+$232M
(-14%)
Cap. Flow
-$109M
Cap. Flow
% of AUM
-46.84%
Top 10 Holdings %
Top 10 Hldgs %
59.19%
Holding
75
New
16
Increased
5
Reduced
5
Closed
41
Top Buys
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$80.4M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
$31.4M |
| 3 |
Gossamer Bio
GOSS
|
$8.31M |
| 4 |
Philip Morris
PM
|
$5.4M |
| 5 |
Corebridge Financial
CRBG
|
$4.92M |
Sector Composition
| 1 | Healthcare | 19.43% |
| 2 | Industrials | 8.29% |
| 3 | Consumer Staples | 6.88% |
| 4 | Technology | 4.4% |
| 5 | Energy | 2.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard Total Stock Market ETF
VTI
$526B
| $59.3M | 25.51% | 310,000 -164,000 | -35% | -$31.4M |
|
2
Chart Industries
GTLS
$8.96B
| $11.5M | 4.96% | +100,000 | New | +$11.5M |
|
3
Compass Therapeutics
CMPX
$483M
| $11.2M | 4.83% | 2,230,441 +1,000,000 | +81% | +$5.03M |
|
4
Constellation Brands
STZ
$28.5B
| $9.27M | 3.99% | +40,000 | New | +$9.27M |
|
5
Alight
ALIT
$2.05B
| $8.19M | 3.52% | +979,397 | New | +$8.19M |
|
|
6
Chart Industries, Inc. Depositary Shares, each Representing a 1/20th Interest in a Share of 6.75% Series B Mandatory Convertible Preferred Stock
GTLS.PRB
$569M
| $7.6M | 3.27% | +150,000 | New | +$7.6M |
|
7
Cencora
COR
$56.5B
| $7.46M | 3.21% | +45,000 | New | +$7.46M |
|
8
Laureate Education
LAUR
$4.05B
| $6.72M | 2.89% | +698,304 | New | +$6.72M |
|
|
9
Invesco QQQ Trust
QQQ
$364B
| $6.66M | 2.87% | 25,000 -302,000 | -92% | -$80.4M |
|
10
Aspen Aerogels
ASPN
$563M
| $5.95M | 2.56% | +505,000 | New | +$5.95M |
|
11
AN2 Therapeutics
ANTX
$30.1M
| $4.29M | 1.85% | 450,000 +216,670 | +93% | +$2.06M |
|
12
Roivant Sciences
ROIV
$8.15B
| $3.76M | 1.62% | +470,000 | New | +$3.76M |
|
13
New Fortress Energy
NFE
$675M
| $3.72M | 1.6% | +87,700 | New | +$3.72M |
|
14
Pliant Therapeutics
PLRX
$101M
| $2.9M | 1.25% | 150,000 +50,000 | +50% | +$967K |
|
15
Biohaven
BHVN
$1.63B
| $2.78M | 1.19% | 200,000 -200,000 | -50% | -$2.78M |
|
|
RAIN
16
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $2.51M | 1.08% | +314,171 | New | +$2.51M |
|
|
SLGC
17
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $2.51M | 1.08% | 1,000,000 | – | – |
|
18
Crescent Energy
CRGY
$2.43B
| $2.1M | 0.9% | 175,000 +50,000 | +40% | +$600K |
|
19
indie Semiconductor
INDI
$899M
| $2.04M | 0.88% | +350,000 | New | +$2.04M |
|
|
BLU
20
DELISTED
BELLUS Health Inc.
BLU
| $2.01M | 0.87% | 245,000 +215,000 | +717% | +$1.77M |
|
21
Karyopharm Therapeutics
KPTI
$61.7M
| $1.64M | 0.7% | +481,696 | New | +$1.64M |
|
22
Dyne Therapeutics
DYN
$1.92B
| $1.43M | 0.62% | 123,719 -76,281 | -38% | -$884K |
|
23
Aura Biosciences
AURA
$389M
| $1.38M | 0.59% | +131,640 | New | +$1.38M |
|
24
Terns Pharmaceuticals
TERN
$609M
| $1.25M | 0.54% | +122,500 | New | +$1.25M |
|
|
TE
25
T1 Energy Inc.
TE
$257M
| $1.09M | 0.47% | +125,000 | New | +$1.09M |
|